Ecolab Inc
Q2 2025 Earnings
Market Reaction
S&P 500 over the same 30 days: +2.15%.
Did ECL Beat Earnings? Q2 2025 Results
Ecolab posted a narrow earnings miss in Q2 2025, with adjusted diluted EPS of $1.89 falling just short of the $1.90 consensus estimate by 0.29%, even as the company delivered 13% year-over-year EPS growth fueled by value pricing, volume gains, and productivity improvements. Revenue of $4.03 billion came in 0.17% below estimates and grew just 1.0% year over year, with a 2% drag from the prior-year divestiture of its global surgical solutions business masking underlying organic sales growth of 3%. The single most compelling story of the quarter was the momentum in Ecolab's designated growth engines, particularly Global High-Tech, where innovative cooling technologies for data centers and AI infrastructure drove strong double-digit gains, a trend the company is doubling down on with its announced $1.8 billion acquisition of Ovivo's electronics unit to expand its ultra-pure water capabilities for semiconductor manufacturing. Looking ahead, Ecolab maintained its full-year 2025 adjusted diluted EPS outlook of $7.42 to $7.62, representing 12% to 15% growth, and guided Q3 2025 EPS to $2.02 to $2.12.
- Value pricing contributed 2% to organic sales growth
- Volume growth of 1% driven by new business wins and breakthrough innovation
- Productivity improvements and SG&A leverage enabled by digital capabilities
- One Ecolab enterprise selling strategy driving share gains across segments
- Growth engines (Life Sciences, Pest Elimination, Global High-Tech, Ecolab Digital) collectively grew sales double digits
- Lower supply chain costs in Institutional & Specialty and Life Sciences segments
“The Ecolab team executed very well to deliver another strong quarter of double-digit earnings growth. Our Institutional & Specialty and Global Water segments delivered solid growth, outperforming end-market trends as we benefited from share gains supported by the One Ecolab growth strategy, breakthrough innovation, and strong value pricing. Our growth engines, which include Life Sciences, Pest Elimination, Global High-Tech and Ecolab Digital, collectively grew sales double digits, with very strong operating income growth. All of this, combined with SG&A leverage enabled by our digital capabilities, drove continued robust operating income margin expansion.”
Ecolab CEO, on the earnings call
Forward Guidance & Outlook
Ecolab maintains its full-year 2025 adjusted diluted EPS outlook of $7.42 to $7.62, representing 12% to 15% growth versus 2024 adjusted diluted EPS of $6.65. For Q3 2025, the company expects adjusted diluted EPS of $2.02 to $2.12, representing 10% to 16% growth versus Q3 2024. Management expects to overcome the unpredictable operating environment through strong new business wins, value and surcharge pricing, and improved productivity. The company expects quantifiable special charges in 2025 to be approximately $0.25 to $0.30 per share, principally related to restructuring. The company remains confident in delivering a 20% organic operating income margin by 2027. Life Sciences organic operating income margin is expected to be in the mid-teens in the second half of 2025 as investments continue.
ECL YoY Financials
ECL Revenue by Segment
Figures from SEC filings and company reports. Not investment advice.